Whitney Krueger, PhD

AbbVie
North Chicago, Illinois, United States

AbbVie (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Predictors of Effectiveness of First-line Biologic Disease Modifying Antirheumatic Drug(s) (bDMARD) or Targeted Synthetic DMARD (tsDMARD) Treatment with a Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis

  Saturday, August 27, 2022
  1:30 PM – 1:35 PM CEST